Search Results - jacques+galipeau

9 Results Sort By:
PMU-Embedded Analytics for Online Event Detection and Classification in Power Grids
The energy requirement of the world is increasing exponentially every year. With the power demand sites concentrated in the region with the highest population density, energy production sites must be located remotely. This isolation requires lengthy and complicated grids to be designed and manufactured to transmit power over long distances. Grid failures...
Published: 7/30/2024   |   Inventor(s): Payman Dehghanian, Shiyuan Wang, Li Li
Keywords(s):  
Category(s): Technology Classifications > Industrial or Consumer Tech > Energy Infrastructure and Environment
IFN Gamma Prelicensing for Improved Mesenchymal Stromal Cell Function Post-Thaw
Application Mesenchymal stromal cells (MSC) prelicensed with pro-inflammatory cytokines for improved survival and immunosuppressive properties following cryopreservation. Key Benefits Preserves the immunosuppressive function of MSCs following thawing. Improves effectiveness of transplanted MSCs following cryopreservation. Market Summary Mesenchymal...
Published: 7/30/2024   |   Inventor(s): Jacques Galipeau, Raghavan Chinnadurai
Keywords(s): Biologic, Cell/Gene Therapy, Enzyme/Protein, Immunology/Inflammation
Category(s): TechPub Algolia > Therapeutics, TechPub Algolia > Research Tools
rGIFT15: Recombinant Fusion Protein for the Treatment of Autoimmune Diseases
Application Recombinant fusion protein comprising GM-CSF and interleukin-15 for treating autoimmune diseases. Key Benefits rGIFT15 lacks any post-translation modification such as glycosylation. Market Summary For those suffering from autoimmune diseases current therapies treat the symptoms, but do not provide a cure and currently available immunosuppressant...
Published: 7/30/2024   |   Inventor(s): Jacques Galipeau, Andrea Pennati
Keywords(s): Biologic, Immunology/Inflammation, Microbiology/Infectious Diseases, Oncology
Category(s): TechPub Algolia > Therapeutics
Membrane-anchored Fusokine as Vaccine Adjuvant to Prevent Viral Infection
Application GIFT4 anchored to virus-like particles (VLPs) as a prophylactic vaccine adjuvant to prevent chronic viral infections including HIV, HBV, HPV and influenza. Key Benefits GIFT4-containing VLPs induce higher antibody response than non-adjuvanted VLPs. Effectively induce strong mucosal immune response. Market Summary Currently, there...
Published: 7/30/2024   |   Inventor(s): Baozhong Wang, Richard Compans, Jacques Galipeau, Jiusheng Deng
Keywords(s): Enzyme/Protein, Immunology/Inflammation, Microbiology/Infectious Diseases
Category(s): TechPub Algolia > Vaccines
FIST-15: Interleukin 15, Sushi Domain, and TGF-ß Receptor Fusion Protein Therapeutic
Application A fusion protein that inhibits TGF-β signaling and enhances activation of CD8+ T cells and natural killer (NK) cells with applications in cancer immunotherapy, treatment of chronic viral infections, and cell therapy. Key Benefits Preserves the function of each component, blocking TGF-β signaling while enhancing Interleukin...
Published: 7/30/2024   |   Inventor(s): Spencer Ng, Jacques Galipeau
Keywords(s): Cell/Gene Therapy, Enzyme/Protein, Microbiology/Infectious Diseases, Oncology
Category(s): TechPub Algolia > Therapeutics
Distributed Feedback Fiber Laser Pumped by Multimode Diode Lasers
Researchers at the University of Arizona College of Optical Sciences and Canada's Carleton University recently succeeded in fabricating high reflectivity (>99%) Fiber Bragg Gratings (FBGs) into phosphate glass fibers using UV light and a phase mask technique. With this new manufacturing technique, fiber lasers can be created as single monolithic...
Published: 4/3/2023   |   Inventor(s): Nasser Peyghambarian, Axel Schülzgen, Li Li, Jacques Albert
Keywords(s):  
Category(s): Technology Classifications > Imaging & Optics, Technology Classifications > Imaging & Optics > Lasers & Other Sources
All-Fiber Multicore Fiber Laser Devices
Researchers at the University of Arizona have developed a compact, power-scalable, alignment-free fiber laser that takes a new approach to stabilizing phase-locked operation of multi-core fiber lasers by completely removing all free space optical components. This high-brightness, all-fiber laser package uses passive optical fiber spliced at both ends...
Published: 4/3/2023   |   Inventor(s): Nasser Peyghambarian, Axel Schülzgen, Li Li
Keywords(s):  
Category(s): Technology Classifications > Imaging & Optics, Technology Classifications > Imaging & Optics > Fiber Optics, Technology Classifications > Imaging & Optics > Lasers & Other Sources
GIFT4: GM-CSF and IL-4 Fusion Protein for Treating Cancer and Infectious Diseases
Application A recombinant fusion cytokine that activates host immune responses for the treatment of cancer or infectious diseases and the development of adjuvant vaccines. Key Benefits Retains the immune stimulatory properties of both its parental molecules. Displays novel functions such as direct activation of B cells leading to anti-cancer and...
Published: 10/28/2024   |   Inventor(s): Jacques Galipeau, Jiusheng Deng
Keywords(s): Biologic, Microbiology/Infectious Diseases, Oncology
Category(s): TechPub Algolia > Therapeutics, TechPub Algolia > Vaccines
GIFT7: A Novel Biologic to Treat Chronic Infections and Cancer
Application A peptide therapeutic designed to stimulate an enhanced immune response for the treatment of infectious disease or certain cancers. Key Benefits Induces enhanced proliferation of T-cells compared to existing technologies to compensate for compromised immune conditions. More efficacious in treating or preventing cancers when combined...
Published: 10/17/2024   |   Inventor(s): Jacques Galipeau, Hsiang-Chuan Hsieh
Keywords(s): Biologic, Cell/Gene Therapy, Microbiology/Infectious Diseases, Oncology
Category(s): TechPub Algolia > Therapeutics